Cardiopulmonary function in premature infants with bronchopulmonary dysplasia--a 2-year follow up
T Farstad1, F Brockmeier, D Bratlid
1Department of Paediatrics, University Hospital, Rikshospitalet, Oslo, Norway.
Insights
Premature infants with bronchopulmonary dysplasia (BPD) show persistent severe peripheral pulmonary obstruction and cardiac issues. Follow-up assessments of maximum flow and cardiac function are crucial for managing BPD complications.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Cardiology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants.
- Cardiopulmonary function impairment can persist beyond infancy in BPD survivors.
Purpose of the Study:
- To evaluate cardiopulmonary function in infants with BPD and controls at corrected ages of 50 and 120 weeks.
- To identify long-term respiratory and cardiac sequelae in infants with BPD.
Main Methods:
- Longitudinal assessment of respiratory system compliance, resistance, and maximum flow at functional residual capacity (VmaxFRC).
- Doppler echocardiography to assess cardiac involvement.
- Comparison between infants with BPD and premature controls.
Main Results:
- Reduced respiratory compliance and increased resistance improved with age in both groups.
- Severe peripheral pulmonary obstruction (VmaxFRC < 84 ml/s) persisted in 5/13 BPD infants at 120 weeks, compared to none in controls (VmaxFRC < 120 ml/s).
- Cardiac involvement (shortened pulmonary acceleration time) was observed in BPD infants with severe obstruction; BPD infants also had higher pulmonary morbidity, were shorter, and weighed less.
Conclusions:
- Maximum flow at functional residual capacity and cardiac evaluation are essential for monitoring infants with severe BPD.
- Persistent peripheral pulmonary obstruction and cardiac involvement are significant long-term issues in BPD.
- Early identification and management of cardiopulmonary complications are vital for improving outcomes in BPD survivors.
Abstract:
Twenty-three premature infants (GA 28.8 +/- 0.5 weeks) with bronchopulmonary dysplasia (BPD) and 14 premature infants (controls, GA 33.0 +/- 1.2 weeks) with moderate respiratory distress syndrome or with mild respiratory disturbances, were evaluated for impairment of cardiopulmonary function at 50 and 120 weeks corrected age. Respiratory system compliance was reduced in both groups, but improved with advancing age. Respiratory system resistance was initially increased, especially in the BPD group, but improved gradually. Maximum flow at functional residual capacity (VmaxFRC ml/s) indicated, nevertheless, severe peripheral obstruction (flow < 84 ml/s) in 16/20 of infants with BPD and in 7/12 of control infants at 50 weeks corrected age. At 120 weeks corrected age none of the control patients had severe peripheral pulmonary obstruction (flow < 120 ml/s), while this was still found in 5/13 infants with BPD. Doppler echocardiography indicated cardiac involvement (shortened pulmonary acceleration time) in patients with the most severe peripheral pulmonary obstruction. Pulmonary morbidity was also higher in the BPD group, and these infants were shorter and weighed less than the control infants. CONCLUSION. Measurements of maximum flow at functional residual capacity as well as cardiac evaluation are essential elements in follow up of infants with severe BPD.
Related Concept Videos
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Atelectasis II: Pathophysiology
Chronic Obstructive Pulmonary Disease II: Emphysema


